v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
SCHEDULE OF DEFERRED INCOME TAX ACTIVITY

The following table summarizes the deferred income tax activity for the year ended March 31, 2026:

 

   Orocidin   Bio-Convert   Total 
Balance as of March 31, 2025  $3,449,767   $5,868,647   $9,318,414 
Foreign currency translation adjustment   225,776    510,177    735,953 
Balance as of March 31, 2026  $3,675,543   $6,378,824   $10,054,367